On July 16, 2025, Steris (STE) stock lagged the S&P 500 Index gain but outperformed the Health Care Select Sector SPDR Fund (XLV) decline. Kritika Sarmah had no positions in STE.
1 report, 1 independent
Updated Jul 16
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
On July 16, 2025, Steris (STE) stock lagged the S&P 500 Index gain but outperformed the Health Care Select Sector SPDR Fund (XLV) decline. Kritika Sarmah had no positions in STE.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Steris
medical device company
Nothing else this week.
Coverage
Newest first; wire copies grouped- BarchartWhat to Expect From STERIS' Next Quarterly Earnings Report Mentor, Ohio-based STERIS plc (STE) provides infection prevention products and services worldwide. With a market cap of $22.2 billion, the c